Tag: Editor Pick

In the United States, research and monitoring of airborne organisms is split between an array of federal agencies. The USDA ...

Self-Swabs vs. Caregiver Swabs for COVID Tests: New Study Shows Similar Accuracy

Self swabs and caregiver swabs are effective at detecting multiple pathogens and are just as accurate as those taken by ...

New Vaccine Development Platform Could Fight Deadly, Multi-Drug Resistant Bacteria

A new vaccine development platform has proven effective in protecting against deadly, hard-to-treat infections caused by multi-drug resistant bacteria, thanks ...

Should People Who Have Recently Had COVID-19 Be Vaccinated?

A recent report from Public Health England showed that 83% of people who had had COVID were protected from reinfection ...

Naval Medical Center San Diego Administers Hospital’s First mAb Treatment to COVID-19 Patient

Naval Medical Center San Diego (NMCSD) administered the hospital’s first monoclonal antibody (mAb) treatment to a COVID-19-positive patient Jan. 26. ...

COVID-19 Misinformation on Chinese Social Media – Lessons for Countering Conspiracy Theories

Conspiracy theories about COVID-19 have accompanied the pandemic from the beginning. Crucial to managing the pandemic is mitigating the effects ...

Travelers From Italy May Have Driven First US COVID-19 Wave More Than Those From China

The coronavirus was still a far-away problem in Wuhan when U.S. President Donald Trump announced a ban on travel from ...

Rigel Awarded $16.5 Million from DoD for Phase 3 Trial of Fostamatinib in COVID-19 Patients

Rigel Pharmaceuticals, Inc. announced on Jan. 29 it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program ...

Why Combining the Oxford COVID-19 Vaccine with Russia’s Sputnik V Could Make It More Effective

January 28, 2021

When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion. The overall efficacy of ...

DoD Awards Funding to Pulmotect to Study Repurposed PUL-042 Against COVID-19

January 27, 2021

The Department of Defense (DOD) awarded a $6 million agreement to Pulmotect, Inc., a clinical-stage biotechnology company, to execute two ...

SARS-CoV-2 Stem-Loop II Motif: Potential Target for Anti-viral Drugs

While the world awaits broad distribution of COVID-19 vaccines, researchers at Ohio University just published highly significant and timely results ...

SARS-CoV-2 Reacts to Antibodies of Virus from 2003 SARS Outbreak

OHSU study has important implications for vaccines, diagnosis of COVID-19 Antibodies generated by the novel coronavirus react to other strains ...

At the Top of the COVID-19 Research Agenda: Asymptomatic Spread and Long-Term Health Impacts

A new research agenda developed by 40 leading experts in healthcare epidemiology and infectious diseases defines the critical areas of ...

Defense Threat Reduction Agency Awards $75M for Antibiotic Drug Development

In the medical and military fields, antibiotic-resistant bacteria can be formidable foes. Now, University of Florida Health researchers and their ...

Air Force Study: Microwaves to Deactivate Coronavirus, Flu, Other Aerosolized Viral Particles

While scientists have previously explored the use of electromagnetic energy to deactivate flu virus in bulk fluids, less work has ...

Risk of Severe COVID Established Early in Infection

Why most people who get COVID have mild symptoms or none at all while some become severely ill is still ...

NeuroCOVID: New Database to Track Neurological Symptoms Associated with SARS-CoV-2 Infection

A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects ...

Reimagining US Public Health with Robust Application of Systems Engineering

Of the many things that COVID-19 has made abundantly clear to us, surely one of them is a newfound realization ...

For Some, GI Tract May Be Vulnerable to COVID-19 Infection